Moderna

A*STAR, Flagship Pioneering jointly commit US$100 mil to spur biotech innovation in S’pore, APAC - THE EDGE SINGAPORE

Company in the news

A*STAR, Flagship Pioneering jointly commit up to US$100 mil to spur biotech innovation in S’pore, APAC

Flagship is best known for its role in backing Moderna, which created a widely-used Covid-19 vaccine. Flagship opened a regional hub in Singapore in November 2023.
Moderna investor Flagship Pioneering expands into APAC with Singapore regional hub - THE EDGE SINGAPORE

Company in the news

Moderna investor Flagship Pioneering expands into APAC with Singapore regional hub

Flagship currently counts 43 companies in its ecosystem, spanning human therapeutics, agriculture and nutrition.

Medtech

Moderna to establish new subsidiary in Singapore to support delivery of mRNA vaccines and therapeutics

Further to its announcement, Moderna is actively recruiting a team to build a strong presence in the market.

Covid-19

BioNTech says its Covid vaccine revenue may be lower this year

It is still not clear how many countries will pursue yet another round of shots later in the year.

Covid-19

Moderna says it has US$18.5 billion in vaccine orders for 2022

Analysts were expecting US$19.3 billion in Moderna Covid vaccine sales for 2022

Tech

Top tech trends to watch in 2022

We tend to overestimate the short-term potential of any new technology and, way underestimate its longer-term potential
Moderna CEO sparks slump reiterating omicron may need new shots - THE EDGE SINGAPORE

Covid-19

Moderna CEO sparks slump reiterating omicron may need new shots

There is no way the current shots will provide the same level of protection against omicron as they do against delta.
Omicron — it’s Black Friday! - THE EDGE SINGAPORE

Global Markets

Omicron — it’s Black Friday!

Fortunes have been made in past fire sales. Happy holidays!
Moderna says new vaccine for omicron may be ready in early 2022 - THE EDGE SINGAPORE

Covid-19

Moderna says new vaccine for Omicron may be ready in early 2022

"The remarkable thing about the mRNA vaccines, the Moderna platform, is that we can move very fast."
Singapore to accelerate vaccine schedule, reveals Novavax prepurchase agreement - THE EDGE SINGAPORE

Covid-19

Singapore to accelerate vaccine schedule, reveals Novavax prepurchase agreement

Singapore allows PRs and LTP holders to register for vaccinations from Jul 2, reveals it has prepurchase agreement for Novavax.
×